Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.
about
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney diseaseHeparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adultsA randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients--the HEALTHY-CATH trial.Preventing catheter-related infections in children undergoing hemodialysis.
P2860
Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Rationale and design of the HE ...... ion in Haemodialysis patients.
@ast
Rationale and design of the HE ...... ion in Haemodialysis patients.
@en
type
label
Rationale and design of the HE ...... ion in Haemodialysis patients.
@ast
Rationale and design of the HE ...... ion in Haemodialysis patients.
@en
prefLabel
Rationale and design of the HE ...... ion in Haemodialysis patients.
@ast
Rationale and design of the HE ...... ion in Haemodialysis patients.
@en
P2093
P2860
P50
P356
P1433
P1476
Rationale and design of the HE ...... ion in Haemodialysis patients.
@en
P2093
Barbara C Johnson
E Geoffrey Playford
Jennifer K Broom
Neil P Underwood
Nicole M Isbel
Sally Carpenter
Scott B Campbell
Sridevi Govindarajulu
Stacey O'Shea
P2860
P2888
P356
10.1186/1471-2369-10-23
P577
2009-08-20T00:00:00Z
P5875
P6179
1004538288